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Background:We aimed to examine physical trauma as a risk factor for the subsequent diagnosis of MS.
Methods:We searched for observational studies that evaluated the risk for developing MS after physical trauma
that occurred in childhood (≤20 years) or “premorbid” (N20 years). We performed a meta-analysis using a
random effects model.
Results:We identiﬁed 1362 individual studies, of which 36 case–control studies and 4 cohort studies met the in-
clusion criteria for the review. In highquality case–control studies, therewere statistically signiﬁcant associations
between those sustaining head trauma in childhood (OR = 1.27; 95% CI, 1.12–1.44; p b 0.001), premorbid head
trauma (OR = 1.40; 95% CI, 1.08–1.81; p = 0.01), and other traumas during childhood (OR = 2.31; 95% CI,
1.06–5.04; p = 0.04) and the risk of being diagnosedwithMS. In lesser quality studies, therewas a statistical as-
sociation between “other traumas” premorbid and spinal injury premorbid. No association was found between
spinal injury during childhood, or fractures and burns at any age and the diagnosis of MS. The pooled OR of
four cohort studies looking at premorbid head trauma was not statistically signiﬁcant.
Conclusions: The result of themeta-analyses of highquality case–control studies suggests a statistically signiﬁcant
association between premorbid head trauma and the risk for developing MS. However, cohort studies did not.
Future prospective studies that deﬁne trauma based on validated instruments, and include frequency of traumas
per study participant, are needed.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Multiple sclerosis (MS) is a multi-factorial disease which results
from complex interactions between susceptibility genes and environ-
mental factors [1]. Whether physical trauma plays a causal role in the
etiological pathway of MS has been debated since the earliest descrip-
tions of the illness [2]. Some scientists argue that physical trauma,
particularly involving the spinal cord and/or the brain may cause a dis-
ruption in the blood–brain barrier, which in turn could lead to the de-
velopment of MS plaques in those who are already genetically at risk
[3]. Thus, the controversy is notwhether physical trauma in itself causes
MS, but rather whether those with the genetic link with predisposing
risk factors (such as Epstein Barr virus), who sustain signiﬁcant physical
trauma, may activate an otherwise dormant MS.
The majority of studies related to physical trauma and MS have
either been case reports or smaller case–control studies, which havealth Studies, Faculty of Health
Athabasca, Alberta T9S 3A3,
ny).
. Open access under CC BY-NC-ND licnot only generated contradictory results but also produced effect sizes
too small to resolve the hypothesis of an association between trauma
and the eventual diagnosis of MS. Three record linkage studies [4–6] and
one prospective cohort study [7] were published on the subject. One
major review on the topic was published in 1999 [8], and a recent meta-
analysiswas conducted byWarren et al. in 2013 [9].We feel it is necessary
to report our results as the Warren study only included 13 case control
studies, and three cohort studies, as opposed to our meta-analysis which
reported on the pooled results of 36 case–control studies and four cohort
studies. Furthermore, our results are classiﬁed more rigorously.
2. Methods
We followed the procedures for conducting systematic reviews and
meta-analysis as outlined by the Cochrane Collaboration [10] and the
reporting guidelines of the Meta-Analysis of Observational Studies in
Epidemiology (MOOSE) group [11].
2.1. Search strategy
Studies were identiﬁed by several methods. First, we searched for
completed reviews in the Database of Abstracts of Reviews of Effects
(DARE), the Evidence for Policy and Practice Information (EPPI) Centre,ense.
14 C.A. Lunny et al. / Journal of the Neurological Sciences 336 (2014) 13–23theHealthEvidence.cawebsite, and the Cochrane Database of Systematic
Reviews. We searched for individual studies in the MEDLINE, Web of
Science, PubMed, and the LILACS (Latin American and Caribbean
Computer Library Center) databases. The Google Web search engine
(www.google.com) and Google Scholar (scholar.google.com) were
used to locate articles that may not have been included in the
above databases. Gray literature was searched using OpenSIGLE,
NTIS, Health Management Information, British National Bibliogra-
phy for Report Literature, Proquest Dissertations and Theses, Disser-
tation Abstracts, CINHAL, and CyberTesis.
For the electronic search, we used the following search terms:
(a)multiple sclerosisOR demyelinating disease; (b) craniocerebral trauma,
whiplash, hyper ﬂexion, concussion, trauma, injury, accident, fracture, burn,
contusion, sprain, spinal cord injury, cervical cord injury, skull fracture,
unconsciousness, and loss of consciousness; and (c) etiologic factor, associ-
ation, risk factor, causation, case–control, cohort, latent, or onset. Reference
lists of all relevant articles were examined for further pertinent studies.
Forward citation searches of included studies and literature reviews
were also done. Primary authors and experts in the ﬁeld were contacted
to identify additional published, unpublished, or ‘in-progress’ studies.
The searchwas not limited by publication date, language, or publication
status. All databases were last accessed in March 2013.
2.2. Inclusion criteria
We planned to include a broad range of observational studies:
cohort, case–control, and cross sectional designs. As there were few
primary studies, we also planned to include retrospective studies
utilizing secondary data from healthcare databases. To be eligible for in-
clusion, studies needed to include patientswith physiciandiagnosedMS
(preferably using diagnostic criteria) and report original data. Studies
were excluded if there was no control group. The primary outcome of
interest was the development of MS following a past history of physical
trauma (exposure variable). Due to the estimated mean latency period
of MS, exposure categories were divided by age at the time of trauma:
(1) age ≤20 years and (2) age N20 years (or premorbid).
2.3. Data collection and analysis
2.3.1. Selection of studies
One of the study investigators (CL) performed the initial search of all
databases to identify potentially relevant citations. Where it was not
possible to accept or reject the study, the full text of the citation was
obtained for further evaluation. Following the screening of titles and ab-
stracts, the full texts of potential articles were retrieved (and translated
into English where required) and assessed for inclusion independently
by two of the study investigators (CL, SF). If any differences in opinion
occurred, they were resolved by consensus with a third reviewer.
2.3.2. Data extraction and management
Data were independently extracted by one unmasked reviewer (CL)
using a standardized electronic data collection form and checked by a
second reviewer (JKS) for accuracy. When raw data were not provided,
the data were extracted from ﬁgures; where necessary, we attempted
to seek additional information from ﬁrst or corresponding authors via
electronic mail. We attempted to extract the following information:
source of cases and controls, eligibility criteria, sampling methods, par-
ticipant demographics, MS diagnostic information, covariates adjusted
for, outcome exposures, and results. Geographic latitude was assigned
according to the latitude of the nearest major city to where the study
was conducted or where the majority of study subjects lived. This
method has been used by other researchers [12].
2.3.3. Quality assessment: risk of bias in included studies
After identiﬁcation of articles meeting the inclusion criteria, two
review authors (CL, JKS) independently assessed the methodologicalquality of studies according to the criteria of the Newcastle–Ottawa
Quality Assessment Scale (NOS) as recommended by the Cochrane Col-
laboration for assessing the quality of non-randomized studies [13]. The
NOS is based on a cumulative score in each of three broad categories:
selection of study groups, comparability of their cases and controls,
and their ascertainment of the outcome/exposure on cases and controls.
If a study fulﬁlls the criteria for an item, a score of 1 point is allocated,
with the exception of comparability which can score up to 2 points,
resulting in a maximum score of 9. Similar to other reviews, we con-
sidered studies that received a score of ≥6 on the NOS criteria to be
of high quality. We speciﬁcally classiﬁed studies as high risk of bias
(1–3 points), medium risk of bias (4–5 points), or low risk of bias
(6–9 points). In the case of disagreement between reviewers, differ-
ences were to be resolved by discussion until consensus was achieved.
2.3.4. Dealing with missing data
When missing data were evident, we attempted to contact study
authors. When data could not be obtained from authors, available data
were extracted and missing data were imputed. For those studies
reporting “no signiﬁcance”, with no additional statistical data, we as-
sumed an odds ratio (OR) of 1.0 and estimated the conﬁdence intervals
(CIs) based on the number of reported MS cases [12]. Sensitivity analy-
ses were performed to check the effect of imputation.
2.3.5. Assessment of heterogeneity and reporting bias
Heterogeneity between studies was examined visually using the
I2 statistic. Deeks and colleagues (for the Cochrane Collaboration) [14]
suggest the following as a rough guide for interpreting the I2 statistic:
• 0% to 40%: might not be important;
• 30% to 60%: may represent moderate heterogeneity;
• 50% to 90%: may represent substantial heterogeneity;
• 75% to 100%: considerable heterogeneity.
Possible sources of heterogeneity were assessed by sensitivity analy-
ses and described qualitatively in Table 1.
Stratiﬁed meta-regression, based on sub-groups including 10 or
more studies, was performed to further examine heterogeneity. Odds
ratios (β) and 95% CIs were calculated using the study level log OR
and the standard error (SE) of the estimate by constructing univariate
random effects (RE) meta-regression models in STATA 12 using the
megareg command. A plot of ORswas done against NOS scores to deter-
mine if there was a linear relationship between the methodological
quality of the studies and their results [15]. We also explored publica-
tion bias and other potential reporting biases, in those pooled compari-
sons with 10 or more studies, using funnel plots. We used the graphical
approach for funnel plots as described by Peters et al. for assessing
dichotomous outcomes with effects measured as ORs [16].
2.3.6. Subgroup analysis and investigation of heterogeneity
A priori, we planned to explore and address possible clinical hetero-
geneity as well as to investigate the magnitude and precision of effects
by performing subgroup analyses based on the reported classiﬁcation
of “trauma”. Unfortunately, the grouping of exposures reported in
the epidemiological studies was problematic as the majority did not
make explicit the type of trauma or the reported varying deﬁnitions
of “trauma.” For example, some studies included only severe cases of
head trauma [6], others grouped head trauma with brain or spinal
traumas [17], and some did not deﬁne the type of head trauma included
at all [18]. We therefore aimed to group the studies together using the
outcome name/term reported in the studies, e.g. “head trauma” and
reported on the following classiﬁcations of trauma:
1. Head trauma, including the terms: “head trauma”, “brain trauma”,
“loss of consciousness”, and “concussion”
2. “Other trauma”, including the general term trauma, and other terms
such as “accidents” and “injuries”
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4. Fractures
5. Burns.
Sub-group analyses were also done based on population-level con-
tinuous variables (latitude, female-to-male case ratio, and mean age
of MS onset) and various study-level variables (study quality [NOS
score], language of publication [English vs. non-English], publication
type [published vs. unpublished], number ofmatching variables, sample
size [≤100 vs. N100], and number of MS cases [≤100 vs. N100]).
2.3.7. Effect measurement and data synthesis
Meta-analyses were performed using the Cochrane Collaboration
software program ReviewManager (Rev Man) Version 5.1 [19]. To esti-
mate the strength of association between variables, data were pooled
using the inverse variance (IV) approach to calculate the OR and 95%
CIs and statistical signiﬁcance was set at p b 0.05. When interpreting
results of the forest plots for dichotomous data, the area to the right
side of the forest plot graph (N1) favored the control group. Studies
were weighted based on sample size and the number of events.
Meta-analysis methods were selected based on study heterogeneity
and the number of studies included in the analyses.When the I2 statistic
was greater than 75%, we considered it substantial heterogeneity and
pooled the study results using an RE model [20]. As we expected in sta-
tistical heterogeneity in the majority of outcomes, the RE model was
used for all analyses.
2.3.8. Sensitivity analysis
We performed sensitivity analyses by examining the results of the
meta-analysis under different assumptions and checked for robustness
of the observed ﬁndings. A priori, the following sensitivity analyses
were planned:
1. By limiting included studies in the analyses to thosewith the highest
methodological quality (NOS score of ≥6), do the results change?
2. For studies in which the OR was reported as “not signiﬁcant” and
therefore had to be imputed, do the results of the pooled analysis
change if these are excluded from the results?
3. Results
3.1. Characteristics of included studies
After excluding duplicate studies, we identiﬁed 1359 individual
studies, of which 83 potentially relevant studies passed the ﬁrst
screening and were retrieved for closer examination. Of the 83 full
text articles reviewed, 43 were excluded for the following reasons: 17
did not examine physical trauma [21–37]; 10 did not have a control
group [38–47]; seven had a diagnosis other than MS [48–54]; seven
were review articles [55–60]; one had insufﬁcient data, andwewere un-
able to locate study authors [61]; and in one study, trauma occurred after
the diagnosis of MS was made [62]. Of the retrieved articles, 40 studies
met the inclusion criteria for the systematic review [4–7,17,18,63–96].
Fig. 1 outlines the study selection process.
There were 36 case–control studies [17,18,63–96], one had in-
sufﬁcient data to be included in the majority of analyses [89]. The
remaining four studies were cohort studies [4–7], three of which
were record-linkages [4–6]. Six case–control studies had less than
100 participants in total, and 30 case–control studies had less
than 100 cases included. Studies were published between 1965
and 2013 with the majority published in European countries
[4,7,18,66,68–71,73,75,76,80–82,85,87,88,91,93], followed by North
American [6,63,65,67,72,74,77–79,86,95,96], and Middle Eastern
countries [64,83,90,92,94].
Twenty-two different trauma related exposures were reported in
the 40 studies. With the exception of four studies [4–7], the risk for
MS was reported as ORs while others simply reported whether theexposure risk for MS was “signiﬁcant” or “not signiﬁcant”. The ORs
ranged from 0.59 to 7.34. Fifteen independent studies reported statisti-
cally signiﬁcant results for speciﬁc exposures [5,18,64,69,70,74–
76,83,85,87,88,90,91,94], while the remaining 25 did not. Details of
the 40 studies are summarized in Table 1 Characteristics of included
studies.
3.2. Quality assessment
When stratiﬁed by study design, themeanNOS score for the 36 case–
control studies was 4.8 (medium risk of bias) with seven of the case–
control studies classiﬁed as having a high risk of bias (1–3 points)
[18,65,69,70,72,73,76], 16 had a medium risk of bias (NOS score of 4–5
points) [17,63,64,66,68,74,79,81,82,84,87,90,93–96], and nine had a
low risk of bias (NOS scores of 6–9 points) [67,77,78,80,85,86,88,91,92].
Four case–control studies could not be classiﬁed due to a lack of available
data [71,75,83,89]. The mean NOS score for the cohort studies was 7.3
(low risk of bias). One cohort study was classiﬁed as medium risk of
bias [6] while the three remaining studies were considered as low risk
of bias [4,5,7].
3.3. Exposure results: case–control studies
The meta-analysis of case–control studies included data from all 36
included studies with 6664 MS cases and 7521 controls; there were
twice as many females than males included in the studies and the
mean age at MS diagnosis was approximately 29 years. See Table 2 for
pooled trauma exposure results.
3.3.1. Head trauma
Of the 21 separate studies reporting on head trauma, eight examined
head trauma occurring at ≤20 years, and 21 examined head trauma
occurring before the diagnosis of MS or “premorbid”. The eight case–
control studies pertaining to head trauma occurring at ≤20 years
[67,70,75,76,80,82,85,91] included 3695 cases and 3504 controls. The
pooled RE model revealed a homogeneous sample (I2 = 0%; p = 0.43)
with a statistically signiﬁcant relationship between head trauma and
MS diagnosis (OR = 1.26; 95% CI, 1.12–1.42; p b 0.001). We performed
sensitivity analysis based on study quality (removing those studies with
an NOS score b6). Removing the four studies [70,75,76,82] with an NOS
score of b6 still allowed for a homogeneous sample (I2 = 0%; p = 0.52)
and there were no changes in the direction or magnitude of the effect
(OR = 1.27; 95% CI, 1.12–1.44; p b 0.001). Sensitivity analysis based
on removing the one study where the OR was imputed [82] did not
change the signiﬁcance nor magnitude of the effect (OR = 1.28; 95%
CI, 1.14–1.45; p b 0.001).
The 21 studies examining premorbid head trauma included 2574
MS cases and 2990 controls [17,18,63,65,67,70,73–76,78,80,81,84,
85,87,88,93–96]. The pooled RE model displayed a homogeneous
sample (I2 = 9%; p = 0.34) with a statistical difference between
groups (OR = 1.65; 95% CI, 1.39–1.95; p b 0.001). When 16 studies
[17,18,63,65,70,73–76,81,84,87,93–96]with anNOS score of b6were ex-
cluded, the homogeneous results changed slightly as precision increased
but p value decreased while still remaining signiﬁcant (OR = 1.63; 95%
CI, 1.10–2.42; p = 0.01). Sensitivity analysis based on removing the
ﬁve studies [65,78,85,87,88] where the ORwas imputed did not improve
the heterogeneity (I2 = 27%; p = 0.17) nor change the signiﬁcance
and magnitude of the effect (OR = 1.66; 95% CI, 1.25–2.22; p b 0.001).
See forest plot of the results presented in Fig. 2.
3.3.2. Other traumas
There were 20 discrete studies that examined “other physical
traumas”; seven examined other traumas occurring in those
≤20 years and 16 examined other traumas in patients “premorbid”.
The seven studies reporting on “other traumas” in patient's ≤20 years
[64,67,71,72,83,85,89], involved 595 MS cases and 1352 controls. The
Table 1
Characteristics of included case–control and cohort studies.
Author (year) country MS cases
(n)
Control
group (n)
F:M ratio
(MS cases)
Mean age at
MS onset (y)
LAT NOS
score
MS Dx
criteria
Timing of
trauma
Matched variables Name of exposure
variable(s)
ORa (95% CI)
Case–control studies
Al-Afasy (2013) Kuwait 101 202 1.80 –b 32 5 N Pre Age, sex, nationality, age at onset Head trauma 2.6 (1.2–5.5)⁎
Alter & Speer (1968) USA 36 72 –b –b 45 4 N Pre Age, sex, age at onset Head trauma 1.37 (0.59–3.21)
Antonovsky (1965) Israel 241 964 1.10 –b 31 5 N ≤15 y,
N15 y
Age, sex, age of onset, region of
birth
Trauma ≤15 y: NSc
N15 y: 1.82 (1.28–2.58)⁎
Bamford (1981) USA 82 82 –b –b 32 3 K Pre Age, sex (1) Trauma
(2) Head trauma
(3) Spine injury
(4) Fractures
(1) 1.75 (0.74–4.12)
(2) NSc
(3) NSc
(4) NSc
Berr (1989) France 63 63 2.70 30.8 42 5 P Pre Age, sex, residence Trauma 1.17 (0.54–2.53)
Bobowick (1978) USA 10 8 –b 29.7 40 6 N ≤20 y Age, sex (1) Head trauma,
(2) Trauma,
(3) Burns
(1) 1.75 (0.13–23.7)
(2) 7.0 (0.61–79.87)
(3) 2.68 (0.10–75.1)
Casetta (1994) Italy 104 150 2.0 32.2 44 5 Mc Pre Age (N3 y), sex, residence Trauma NSc
Currier (1974) Ireland 60 60 1.4 26 53 3 A Pre Age, sex, social class, marital
status
(1) Trauma
(2) Burns
(1) 1.60 (0.78–3.31)
(2) 3.50 (1.06–11.57)⁎
da Silva (2009) Brazil 81 81 2.10 –b 22 4 N Pre Age, sex, place of birth Head trauma 1.36 (0.56–3.30)
de Gennaro (2009) Italy & Serbia 104 150 2.06 28 44 3 M ≤15 y,
N15 y
Age, sex, residence (1) Head trauma
(2) Fractures
(3) Spinal trauma
(1) ≤15 y: 1.89 (0.72–4.96), pre: 2.55 (1.40–4.64)⁎
(2) Pre: 1.59 (0.96–2.64)
(3) ≤15 y: 7.34 (0.35–154.51), pre: 1.52 (0.71–3.26)
Dokuchaeva (2006) Russia 178 178 2.80 –b 48 –b –b ≤15 y,
N15 y
Age, sex, ethnic origin Trauma NSc
Dolan (2003) USA 24 24 2.0 35.4 42 3 P b20 y Age, sex Trauma 2.14 (0.63–7.33)
Fernandez (1990) Spain 43 41 1.69 28.3 45 3 P Pre Age, sex (1) Head trauma
(2) Spinal trauma
(3) Fractures
(1) 1.95 (0.17–22.38)
(2) 0.95 (0.06–15.75)
(3) 0.95 (0.06–15.75)
Fraser & Lunny (2013) USA 493 493 1.45 39.7 42 5 N Pre Age, sex, age at onset (1) Head trauma
(2) Spinal trauma
(3) Fractures
(1) 1.30 (0.84–2.00)
(2) 1.75 (1.06–2.89)⁎
(3) 1.25 (0.81–1.86)
Ghadirian (2001) Canada 197 202 2.17 –b 45 5 N Pre Age, sex Head trauma 3.01 (1.06–8.53)⁎
Goncharova (2009) Russia 122 122 –b –b 56 –b –b ≤15 y,
N15 y
–b Head trauma ≤15 y: NSc
N15 y: 2.13 (1.01–4.50)⁎
Gusev (1996) Russia 155 155 1.63 25.8 56 3 Mc ≤15 y,
N15 y
Age, sex, residence, ethnicity (1) Head trauma
(2) Spinal trauma
(1) ≤15 y: 2.40 (1.10–5.25), ⁎ N15 y: NSc
(2) ≤15 y: 1.51 (0.25–9.16), N15 y: 0.79 (0.21–3.02)
Helmick (1989) USA 22 22 3.4 29 25 6 P Pre Age, sex Trauma 0.98 (0.34–2.85)
Hopkins (1991) USA 14 56 4.30 35.2 41 7 P Pre Age, sex, race (1) Head trauma
(2) Trauma
(1) NSc
(2) NSc
Koch (1974) USA 7 7 2.50 29.3 46 4 N Pre None stated Trauma NSc
Koch-Henriksen (1989)
Denmark
297 297 1.42 32 56 8 A ≤15 y,
N15 y
Age, sex Head trauma ≤15 y: 1.38 (0.72–2.64), N15 y: 1.30 (0.69–2.46)
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Kurtzke (1997) Norway 23 127 1.55 30 62 5 Schum Pre Age, sex (1) Head trauma (1) 2.24 (0.72–6.98)
Lauer (1994) Germany 150 150 2.04 30.3 51 4 B ≤14 y Age, sex, residence Head trauma NSc
Leibowitz (1973) Israel 70 70 –b –b 31 –b N ≤15 y,
N15 y
–b Trauma ≤15 y: 1.00 (0.51–1.96), N15 y: 2.04 (1.00–4.18)⁎
Martinez-Sobrepera (2001)
Cuba
50 50 4.50 –b 21 5 P Pre Age, sex, ethnicity (1) Head trauma
(2) Burns
(1) 2.09 (0.36–11.95)
(2) NSc
Materljan (1994) Croatia 36 72 1.8 24.4 45 6 P ≤18 y, pre Age, sex, residence (1) Trauma
(2) Head trauma
(1) p = 0.046d, ⁎
(2) p = 0.016d, ⁎
McAlpine (1952) England 250 250 1.86 29.6 51 3 N Pre Age, sex Trauma 3.07 (1.58–5.94)⁎
Operskalski (1989) USA 145 145 2.45 30.1 47 9 N Pre Age, age at onset, sex,
birthplace, residence, race
Fracture 0.91 (0.50–1.66)
Rudez (1998) Croatia 132 132 1.8 28 45 4 P Pre Age, sex, residence (1) Head trauma
(2) Trauma
(1) p = 0.04d, ⁎
(2) p = 0.013d, ⁎
Sepcic (1993) Croatia 46 92 2.06 26.4 45 6 P Pre Age, sex, place birth,
residence
Head trauma Signiﬁcantd
von Wilhelm (1970)
Switzerland
36 36 –b –b 51 4 N ≤20 y Gender, age Trauma (accidents and
burns)
NSc
Westlund & Kurland (1952)
Canada
112 123 1.43 30.3 49 5 N Pre Age, sex, age at onset Head trauma NSc
YoseﬁPour (2002) Iran 149 100 1.19 –b 32 4 N Pre Age, sex Trauma 2.17 (1.06–4.43)⁎
Zaadstra (2008) Netherlands 2821 2550 2.30 –b 52 7 N ≤20 y Age, sex, education,
residence
Head trauma 1.24 (1.09–1.41)⁎
Zilber (1996) Israel 70 64 1.73 25.2 31 6 M ≤20 y, pre 1Age, sex Trauma NSc
Zorzon (2003) Italy 140 131 1.72 31.2 45 5 M Pre Age, sex (1) Fractures
(2) Head trauma
(1) 0.66 (0.38–1.16)
(2) 0.96 (0.54–1.72)
Subtotal 6664 7521 2.0 28.8 4.8
Cohort studies
Author (year) country (type) Cohort size F:M ratio
(MS cases)
LAT NOS score MS Dx criterion Mean follow up
(y)
Adjustment Exposure
variable(s)
SIRa
(95% CI)
Goldacre (2006) England (record linkage) 110,993 –b 51 8 Hospital admission for MS 16.7 Age, sex Head trauma 1.12 (0.91–1.39)
Kang (2011) Taiwan (record linkage) 72,725 1.12 25 8 N 6 –b Head trauma 1.48 (1.01–2.16)e, ⁎
Pﬂeger (2009) Denmark
(prospective/record linkage study)
150,868 0.56 56 7 A 22 Age, sex, year Head trauma 0.94 (0.77–1.15)
Siva (1993) USA (record linkage) 819 (head trauma cases) 2.47 44 6 Workshop on the Diagnosis of MS 0.5 Residence Head trauma NSc
Subtotal 335,405 1.38 7.25
A = Allison &Miller criteria, B = Bauer criteria, CI = conﬁdence interval, Dx = diagnosis, F:M cases = ratio of female tomaleMS cases, K = Kurtkze criteria, LAT = latitude, LOC = loss of consciousness, Mc = McAlpine criteria, M = McDonald
criteria, MS = multiple sclerosis, NOS = Newcastle–Ottawa Scale, N = neurologist diagnosed, NS = not signiﬁcant, OR = odds ratio, P = Poser criteria, Pre: premorbid, age not speciﬁed other than surgery occurring before MS diagnosis,
RR = rate ratio, Schum = Schumacher committee, Y = year(s).
⁎ Indicates statistically signiﬁcant results at p b 0.05.
a Standard incidence ratio (SIR) for risk of MS reported and/or inputted from study data using a random effects model.
b Data not reported/not available.
c Reported as “not statistically signiﬁcant”, no data provided.
d Reported as “statistically signiﬁcant”, no/or limited data provided.
e After adjusting for monthly income and geographic location.
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Search results of potentially
relevant studies
(n = 1323)
Articles (full text) retrieved,
based on title and abstract, for
more detailed evaluation
(n = 83)
Manuscript review and
application of inclusion criteria
Articles excluded (n = 1307)
Based on title and abstract (n = 1296)
Unable to locate full-text article (n = 11)
Articles excluded (n = 43)
Trauma not included in analysis (n = 17)
No control group (n = 10)
Not specific to multiple sclerosis (n = 7)
Review article (n = 7)
Insufficient data-unable to locate author (n = 1)
Trauma occurred after multiple sclerosis diagnosis
(n = 1)
Articles screened on basis of 
title and abstract 
(n = 1362)
Studies included in the review
(Meta-analysis)
Total = 40
Case control studies = 36
Cohort studies = 4
Additional records identified
through manual search
(n = 39)
Fig. 1. Flow diagram of study selection.
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with no statistical difference between groups (OR = 1.12; 95% CI, 0.88–
1.43; p = 0.37). Sensitivity analysis, based on removing those studiesTable 2
Rate ratios for pooled trauma exposures using a random effects model.
Exposure All studies
Incl. studies
(n)
MS cases
(n)
Controls
(n)
Pooled OR
(95% CI)
Level of heteroge
I2 (χ2 p)
Case–control studies
Head trauma
≤ Age 20 y 8 3695 3504 1.26 (1.12–1.42)⁎ 0% (0.43)
Premorbid 21 2524 2940 1.65 (1.39–1.95)⁎ 9% (0.34)
Other traumas
≤ Age 20 y 7 595 1352 1.12 (0.88–1.43) 0% (0.43)
Premorbid 16 1475 2387 1.58 (1.28–1.94)⁎ 16% (0.27)
Spinal injury
≤ Age 20 y 2 259 305 2.28 (0.48–0.74) 0% (0.38)
Premorbid 5 877 921 1.51 (1.06–.14)⁎ 0% (0.89)
Fractures
Premorbid 7 3747 3573 1.09 (0.95–1.24) 0% (0.43)
Burns
Premorbid 3 120 118 1.66 (0.49–5.55) 45% (0.16)
Cohort studies
Exposure Included studies (n) Pooled SIR (95% CI)
Head trauma 4 1.07 (0.92–1.24)
CI = conﬁdence interval, MS = multiple sclerosis, OR = odds ratio, Y = years.
⁎ Indicates statistically signiﬁcant results at p b 0.05.
a Studies had an NOS score of under 6; therefore analysis was not warranted.[64,71,72,83,89] with an NOS score of b6, signiﬁcantly increased
the magnitude of the effect size but not the precision of the result
(OR = 2.31; 95% CI, 1.06–5.04; p = 0.04). Further sensitivity analysis,Studies with NOS score ≥6
neity Test for overall
effect Z (p)
Pooled OR
(95% CI)
Level of heterogeneity
I2 (χ2 p)
Test for overall
effect Z (p)
3.89 (b0.001) 1.27 (1.12–1.44)⁎ 0% (0.52) 3.66 (b0.001)
5.77 (b0.001) 1.63 (1.10–2.42)⁎ 0% (0.76) 2.45 (0.01)
0.91 (0.37) 2.31 (1.06–5.04)⁎ 0% (0.35) 2.10 (0.04)
4.34 (b0.001) 0.89 (0.53–1.51) 0% (0.53) 0.24 (0.67)
1.04 (0.30) N/Aa N/Aa N/Aa
2.30 (0.02) N/Aa N/Aa N/Aa
1.26 (0.21) N/Aa N/Aa N/Aa
0.82 (0.41) N/Aa N/Aa N/Aa
Level of heterogeneity I2 (χ2 p) Test for overall effect Z (p)
39% (0.18) 0.85 (0.40)
Study or Subgroup
Al-Afasy 2013
Alter & Speer 1968
Bamford 1981
Bobowick 1978
da Silva 2009
de Gennaro 2009
Fernandez 1990
Fraser & Lunny 2013
Ghadirian 2001
Goncharova 2009
Gusev 1996
Hopkins 1991
Koch-Henriksen 1989
Kurtzke 1997
Martinez-Sobrepera 2001
Materljan 1994
McAlpine & Compston 1952
Rudez 1998
Sepcic 1993
Westlund & Kurland 1953
Zorzon 2003
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.01; Chi² = 21.97, df = 20 (P = 0.34); I² = 9%
Test for overall effect: Z = 5.77 (P < 0.00001)
Weight
7.2%
3.7%
6.6%
0.4%
3.4%
7.0%
0.7%
13.2%
2.5%
4.7%
6.2%
1.7%
6.2%
2.1%
1.4%
3.9%
5.9%
8.0%
4.7%
3.1%
7.3%
100.0%
IV, Random, 95% CI
2.50 [1.39, 4.50]
1.37 [0.59, 3.21]
1.28 [0.69, 2.37]
1.75 [0.13, 23.70]
1.36 [0.56, 3.30]
2.55 [1.40, 4.64]
1.00 [0.13, 7.44]
1.27 [0.84, 1.90]
3.01 [1.06, 8.53]
2.13 [1.01, 4.50]
1.00 [0.53, 1.89]
1.00 [0.27, 3.66]
1.30 [0.69, 2.46]
2.24 [0.72, 6.98]
2.55 [0.62, 10.49]
2.03 [0.89, 4.64]
3.07 [1.58, 5.94]
2.08 [1.20, 3.62]
2.18 [1.03, 4.60]
0.99 [0.39, 2.53]
0.96 [0.54, 1.72]
1.65 [1.39, 1.95]
oitaRsddOoitaRsddO
IV, Random, 95% CI
0.2 0.5 1 2 5
No risk Risk
Fig. 2. Forest plot of 21 included studies reportingpremorbidhead trauma (occurringbefore the diagnosis ofmultiple sclerosis) inmultiple sclerosis cases and controls.Horizontal lines, 95%
CIs of each study; squares, odds ratios of each individual study (the size represents theweight that the studywas given in themeta-analysis); diamond, the pooled summary estimate; solid
vertical line, null value. OR N 1 favoured the control group.
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OR, also signiﬁcantly increased the effect size but not the signiﬁcance
of the results (OR = 2.73; 95% CI, 0.91–8.17; p = 0.07). Due to so few
studies included in both sensitivity analyses and the impreciseness
of the results (wide CIs) in addition to the fact that the initial RE
model was statistically homogeneous (I2 = 0%; p = 0.42), we choose
to maintain all seven studies in the ﬁnal analysis.
Of the 16 studies reporting on “other trauma” premorbid
[18,64–69,71,77–79,81,83,87,90,92], there were 1475 MS cases and
2387 controls. The pooled RE results revealed a homogeneous sample
(I2 = 16%; p = 0.27) and statistically signiﬁcant differences between
MS cases and controls (OR = 1.58; 95% CI, 1.28–1.94; p b 0.001). After
removing those studies with an NOS score of b6, four homogeneous
studies [67,77,78,92] remained and the results changed (OR = 0.89;
95% CI, 0.53–1.51; p = 0.67). Sensitivity analysis based on removing
those studies [68,71,78,79,83,87,92] where the OR had to be imputed
did not increase themagnitude of the effect or the precision of the result
(OR = 1.84; 95% CI, 1.45–2.32; p b 0.001). As the initial pooled results
including all 16 studies revealed a homogeneous sample, and the sensi-
tivity analyses were less precise, all 16 studies were included in the ﬁnal
analysis.
3.3.3. Spinal injury
Five discrete studies examined “spinal injury”; two examined spinal
injury occurring in those ≤20 [70,76] (259 cases and 305 controls)
and ﬁve examined premorbid spinal injury [65,70,73,76,94] (877 cases
and 921 controls). Pooled results for the ≤20 subgroup revealed a
non-signiﬁcant and imprecise result, whereas the spinal trauma
premorbid subgroup revealed signiﬁcant results. Speciﬁcally, for the
group ≤20 years the OR was 2.28 (95% CI, 0.48–10.74; p = 0.30;
I2 = 0%, I2 p = 0.38) and the OR for the premorbid group was 1.51
(95% CI, 1.06–2.14; p = 0.02; I2 = 0%, I2 p = 0.89). Sensitivity analysis
for the premorbid group based on removing the one study [65] not
reporting the exact OR, did not change the results (OR = 1.51; 95% CI,
1.03–2.22; p b 0.03). Sensitivity analysis based on study quality could
not be done as all ﬁve studies had NOS scores b6; therefore, they were
included in the ﬁnal analysis.3.3.4. Fractures and burns
The seven studies examining premorbid fractures [65,70,73,86,
91,93,96] included 3747MS cases and 3573 controls. The pooled results
presented a homogeneous sample (I2 = 0%; p = 0.43) with no sta-
tistical differences between groups (OR = 1.09; 95% CI, 0.95–1.24;
p = 0.21). All but one study [86] had an NOS score of b6 therefore sen-
sitivity analysis based on study quality, could not be done. Further sen-
sitivity analysis, excluding the one study [65] where a speciﬁc OR was
not reported, did not improve heterogeneity (I2 = 15%; p = 0.32)
nor signiﬁcantly change the results (OR = 1.09; 95% CI, 0.91–1.30;
p = 0.36).
The three studies reporting on premorbid burns [67,69,84] included
a total of 120 MS cases and 118 controls. Premorbid pooled results re-
vealed a statistically homogeneous sample (I2 = 45%; p = 0.16) and
non-signiﬁcant and imprecise results (OR = 1.66; 95% CI, 0.49–5.55;
p = 0.41). As only one study [67] had an NOS score≥6 sensitivity anal-
yses based on study quality was not done. When we removed the one
study [84] where the OR was imputed, the results becamemore homo-
geneous (I2 = 0%; p = 0.88) and signiﬁcantly changed (OR = 3.40;
95% CI, 1.10–10.46; p = 0.03). As the p-value was of borderline signiﬁ-
cance, and the CI was very wide (imprecise) we choose to maintain the
full more conservative initial model for the ﬁnal analysis.
3.4. Exposure results: cohort studies
Themeta-analysis of four cohort studies, examining premorbid head
trauma [4–7], indicated moderate heterogeneity (I2 = 39%; p = 0.18)
of the pooled RE model, with no statistical relationship between head
trauma and MS diagnosis (OR = 1.07; 95% CI, 0.92–1.24; p = 0.40).
Sensitivity analysis based on study quality was not warranted as all
four studies had NOS scores ≥6; however, we did group the studies
according to design. The one prospective/record linkage cohort study
produced an insigniﬁcant result (OR 0.94, 95% CI 0.77–1.15, p = 0.32),
whereas the three record-linkage studies when pooled produced mod-
erate heterogeneity (I2 = 40%; p = 0.19), and a stronger yet still insig-
niﬁcant effect size (pooled OR 1.12, 95% CI 0.94–1.35, p = 0.21). We
also conducted sensitivity analysis based on removing the one study
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(I2 = 56%; p = 0.10) nor did it change the signiﬁcance of the result
(OR = 1.10; 95% CI, 0.89–1.38; p = 0.34). For that reason, we included
all four studies in the ﬁnal analysis. See Table 2 for pooled trauma expo-
sure results.
3.5. Examining bias
To visually assess for heterogeneity, we plotted the ORs of high
quality (NOS≥6) versus low quality studies (NOS b6). The plot showed
no distinct linear relationship between methodological quality of
studies (NOS score) and ORs, with no obvious clustering, indicating a
low risk of bias.
When funnel plots were examined for the case–control studies
on the outcomes of premorbid head trauma and premorbid “other
trauma”, the plots looked symmetrical indicating a low risk of publica-
tion bias [97]. We further tested these two outcomes with the Peters
test [16], which resulted in non-signiﬁcant publication bias results
(p = 0.72 and p = 0.66 respectively). There was also no evidence of
publication bias with regard to premorbid head trauma and onset MS
risk in cohort studies, as the Peters test was not statistically signiﬁcant
(p = 0.97). Given the small number of studies included in the other
exposure subgroups (b10 studies), the interpretation of funnel plots
must be undertaken with caution and are therefore not included here.
3.5.1. Meta-regression
Meta-regression was performed on the subgroups including at least
10 case–control studies, namely premorbid head traumaand premorbid
“other trauma”. Population-level continuous variables (geographic
latitude, female-to-male MS case ratio, mean age of MS onset) and
study-level dichotomous variables (language [English vs. non-English],
publication type [published vs. unpublished], number of covariatesTable 3
Sensitivity analyses and stratiﬁed meta-regression for assessing heterogeneity among case–con
Exposure variables Head trauma — premorbid
Studies Sub-group Meta-r
n Total
(n)
OR
(95% CI)b
p
Population-level characteristics
Latitude (geographic) 21 5464 1.65
(1.39–1.95)⁎
0.78
Female:male ratio (MS cases) 17 4930 1.68
(1.37–2.06)⁎
0.46
Mean age at MS onset 14 3984 1.58
(1.26–1.97)⁎
0.24
Study-level characteristics
NOS score 20 5222 1.63
(1.36–1.94)⁎
0.54
NOS score (b6 vs. ≥6) 20 5222 1.63
(1.36–1.94)⁎
0.91
Language (English vs. non-English) 21 5464 1.65
(1.39–1.95)⁎
0.24
Pub type (published vs. unpublished) 21 5464 1.65
(1.39–1.95)⁎
0.51
Number of covariatese (≤2 vs. N2) 21 5464 1.65
(1.39–1.95)⁎
0.94
Sample size (≤100 vs. N100) 21 5464 1.65
(1.39–1.95)⁎
0.87
MS cases (≤100 vs. N100) 21 5464 1.65
(1.39–1.95)⁎
0.86
CI = conﬁdence interval, MS = multiple sclerosis, NOS = Newcastle–Ottawa Scale, OR = od
a All analyses weighted by sample size.
b OR (95% CI) were calculated using the random effects model in RevMan.
c β (95% CI)were calculated using the study level log OR and the SE of the estimate (calculate
command.
d All studies were published — analysis not warranted.
e Number of potentially confounding variables adjusted for in individual studies.
⁎ Indicates statistically signiﬁcant results at p b 0.05.adjusted for [≤2 vs. N2], total sample size [≤100 vs. N100], and sample
size ofMS cases [≤100 vs. N100]) for both traumaexposures did not sig-
niﬁcantly inﬂuence the effect sizes. However, signiﬁcant heterogeneity
was noted for both the continuous and categorical variables of the
NOS score in the other trauma premorbid subgroup. That is, the risk
for MS diagnosis decreased as the NOS score increased in those with
premorbid other trauma. Results of the univariate meta-regression are
presented in Table 3.
4. Discussion
In our systematic review and meta-analysis of 36 case–control
studies involving 5922 MS cases and 6667 controls, we found a signif-
icant association between childhood and premorbid head trauma,
other trauma premorbid, and spinal trauma premorbid and the subse-
quent risk for being diagnosed with MS. However, when the results
were stratiﬁed by high quality (NOS ≥6), only head trauma during
childhood and premorbid, other trauma childhood remained statisti-
cally signiﬁcant. Furthermore, signiﬁcant heterogeneity between high
and lower quality study design was noted in meta-regression for
premorbid other trauma; therefore, even the effect size of the higher
quality studies should be interpreted with caution. The ﬁndings of
the meta-analysis of case–control studies did not support an associa-
tion between the other types of physical trauma studied, namely spi-
nal injuries under 20 years of age, fractures, or burns occurring at any
age and the subsequent risk for the diagnosis of MS.
In themeta-analysis of cohort studies, pooled results did not support
a statistical association between head trauma and the later diagnosis of
MS. Only the study of Kang et al. (2011) differed from the other three
cohorts in showing an increased risk of MS after head trauma; however
the difference could be attributed to the different phenotypes of MS in
Asians, perhaps with a different susceptibility to head trauma.trol studies looking at the exposures premorbid head trauma and other trauma.a
Other trauma — premorbid
egression Studies Sub-group Meta-regression
β
(95% CI)c
n Total
(n)
OR
(95% CI)b
p β
(95% CI)c
0.99
(0.97–1.02)
16 3862 1.58
(1.28–1.94)⁎
0.54 1.01
(0.98–1.03)
1.14
(0.78–1.68)
13 3540 1.51
(1.19–1.91)⁎
0.09 0.75
(0.54–1.05)
0.97
(0.91–1.02)
11 1748 1.47
(1.07–2.01)⁎
0.96 1.00
(0.85–1.17)
0.95
(0.81–1.12)
14 3366 1.62
(1.30–2.02)⁎
0.03 0.78
(0.63–0.97)⁎
0.97
(0.56–1.66)
14 3866 1.62
(1.30–2.02)⁎
0.03 0.49
(0.26–0.93)⁎
0.74
(0.44–1.24)
16 3862 1.58
(1.28–1.94)⁎
0.42 0.73
(0.32–1.66)
0.76
(0.32–1.79)
16 3862 1.58
(1.28–1.94)
N/Ad
0.98
(0.63–1.53)
16 3862 1.58
(1.28–1.94)⁎
0.54 0.86
(0.52–1.42)
1.09
(0.37–3.22)
16 3862 1.58
(1.28–1.94)⁎
0.42 1.40
(0.58–3.37)
1.04
(0.65–1.66)
16 3862 1.58
(1.28–1.94)⁎
0.27 1.28
(0.80–2.04)
ds ratio, Pub = publication, SE = standard error.
d in RevMan) by univariate random effectsmeta-regression in STATA 12 using themegareg
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insigniﬁcant results in a general adult trauma exposure including 16
studies (13 case–control and three cohort studies). Their results must
be viewedwith caution as their classiﬁcation of traumawas not as rigor-
ous, as they included half the studies in our review, and they included
children and adults in the samegeneral category (speciﬁcally, the studies
by Gusev [76], von Wilhelm [89], and Zorzon [93]). Furthermore, they
grouped case–control studies examining head trauma [62,75,79,95]
with case–control studies examining a more general trauma category
as the exposure variable [17,64–66,68,73,88].
4.1. Quality of the evidence
When studyparticipants self-reported an episode of head trauma, an
increase in the risk ofMSwasobserved,whichdid not persist after strat-
iﬁcation by study design. The association between premorbid head
trauma and MS diagnosis was weakest for the one prospective/record
linkage cohort study (OR 0.94, 95% CI 0.77–1.15, p = 0.32), weak
for the record-linkage studies (pooled OR 1.12, 95% CI 0.94–1.35,
p = 0.21), strong for case–control studies with an NOS score of 6
or over (OR = 1.40; 95% CI, 1.08–1.81; p = 0.01), and strongest for
all case–control studies (pooled OR 1.65, 95% CI 1.39–1.95, p b 0.001).
Therefore, the strength of the association varies inversely with the
strength of the study design. This may also suggest that event (trauma)
recall bias and clinical heterogeneity (in the selection of study partici-
pants) may have produced a false or inﬂated association in the case–
control comparisons.
It is unlikely though, that our results are prone to publication bias as
the Peters testwas not signiﬁcant and signiﬁcant relationships persisted
during sensitivity analysis. However, since the sensitivity analyses for
the cohort studies showed signiﬁcant clinical and moderate statistical
heterogeneity, investigation into the question of whether head trauma,
other traumas, and spinal trauma indeed pose a risk for the diagnosis of
MS should continue. We would therefore propose several recommen-
dations for researchers who would take up the challenge.
The lack of a consistent and standardized deﬁnition of trauma was
one of the main challenges of this review. All 40 studies included in
the meta-analysis either did not explain how they deﬁned trauma, or
they deﬁned trauma differently, which we consider a limitation in
pooling of the results and may have introduced signiﬁcant bias. In the
future, if studies examine the effect of trauma on the risk forMS diagno-
sis, we suggest using validated severity grading tools for outcomes such
as the traumatic brain injury scale [98]. Further, in case–control studies
using self-report, medically validating the traumatic events would be
ideal, and if this is not possible, having a parent or older sibling validate
the event may minimize recall bias. In a meta-epidemiology study,
Savovic et al. [99] found that average bias and increases in heterogeneity
were driven primarily by trials with subjective outcomes, with little
evidence of bias in trials with objective outcomes. When health records
validate a patients' self-report, the subjective outcome event turns into
an outcomewhich is objectivelymeasured but potentially inﬂuenced by
clinician or patient judgment (for example, hospitalizations) [99].
Despite the variety of outcomes reported in the studies, none
reported on the effects of whiplash or cervical cord demyelination,
which are both frequent events. Furthermore, none of the studies
examined in this review considered the frequency of traumatic injuries
sustained by each participant, which could be seen as a marker of se-
verity and could then have been used to stratify results further.
4.2. Potential bias in the review process
The two review authors who assessed the methodological quality
were not blinded for authors, journal, or institution. The potential bias
caused by the non-blinded quality assessment was expected to be low
as neither review author had a conﬂict of interest. Speciﬁcally, the re-
view authors did not have any (ﬁnancial or other) interest in positiveor negative results. Furthermore, we searched the gray literature exten-
sively for eligible studies, presented the search strategy and the inclu-
sion criteria list, and all of the ﬁnal results of the assessment, so that
readers can make their own determinations of the results and our
conclusions.
There is a possibility of publication bias or study selection bias in
this meta-analysis, as was the case with the Warren meta-analysis
that reported no publication bias, when this was clearly not the case.
For example, by missing unpublished negative studies we may be
over-estimating the association between prior trauma and the risk for
developing MS. However, a comprehensive search of the published
literature for potentially relevant studies was conducted, using a sys-
tematic strategy to avoid bias. This was followed by attempts to contact
corresponding and ﬁrst authors, as we recognize that unpublished or
negative studies may exist.
From the results of our search, we suspect that there was selective
reporting of some outcomes in epidemiology studies, depending
on the nature and direction of the results. Epidemiology studies use dif-
fering outcomes in study questionnaires, andmay only choose to report
on some of them. We attempted to contact authors of epidemiological
case–control studies to ask if they had examined trauma as an outcome,
even though it was not reported; however given that most studies were
published many years ago it would have taken a tremendous effort to
contact all authors to ask them if they had included any traumaoutcome
which they had not reported on.
4.3. Theoretical possibility
Theories linking physical trauma to the onset or exacerbation of MS
date back as far as the time of Charcot who deﬁnedMS in themid 1860s
[2]. Despite the accounts of several researchers, primarily documenting
their observations in either anecdotal or case series reports, a proposed
biological model linking physical trauma and MS has yet to be conclu-
sively established [8]. Some scientists hypothesize that physical trauma,
particularly involving the spinal cord and/or the brain may cause a
disruption in the blood–brain barrier, which in turn could lead to the
development of MS plaques in those who are already genetically at
risk [3]. More speciﬁcally, when the blood–brain barrier is disturbed
autoreactive immune cells are permitted to pass from the blood stream
into the central nervous system where they contribute or activate MS
lesions or plaques in those who are already at risk for developing the
disease. Hence signiﬁcant injury or trauma to the head, neck or spine
may activate an underlying and possibly inherited defect in the small
blood vessels of the brain [3]. Compston goes even further and regards
penetration of the blood–brain barrier as a necessary initial primary
process in the pathogenesis of MS [100]. Yet others note the high fre-
quency of blood–brain barrier breakdown in MS patients without pre-
ceding trauma and the fact that many experience trauma and do not
develop MS thus concluding a purely coincidental, rather than a causal
association [101].
While anecdotal reports and case series have provided important
medical insights into the science of medicine in general, we agree that
conclusions of such inquiry are most useful in providing etiological
clues and ought to be supported by more rigorous evidence. However,
given the long latency period of MS and the unexpected nature of
physical trauma, it is clearly a condition that cannot be studied using
prospective randomized methods in a controlled setting. As a result,
retrospective cohort studies, where a trauma cohort is deﬁned in the
past and followed forward to assess the outcome of MS, are the only
feasible means of studying this condition further.
5. Conclusion
In the meta-analysis of the four cohort studies, pooled results did
not support a statistical association between head trauma and the
later diagnosis of MS. The result of the meta-analyses of high quality
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ation between premorbid head trauma and the risk for developing MS.
More speciﬁcally, thosewith premorbid head traumawere signiﬁcantly
more likely to be diagnosed with MS in comparison to those controls of
similar age and sex who had not sustained head trauma. Despite this
signiﬁcant ﬁnding, this in no way suggests or demonstrates causality,
in that epidemiological studies can only provide etiological clues at
best. More rigorous prospective studies, with high statistical power,
are needed to convincingly establish an association between trauma
and MS. Future prospective studies that take into consideration (a) the
long latency period between the age of putative biological onset and
clinical onset of MS, (b) deﬁne trauma based on validated instruments,
(c) include frequency of traumas per study participant, and (d) include
information on the site of trauma and MRI of the lesion are needed in
order to deﬁnitively rule out any causal links between physical trauma
and MS.
Conﬂict of interest
The authors have no ﬁnancial, personal, or any other kind of com-
peting interests with this paper.
Author contributions
Study concept and design: C Lunny, JA Knopp-Sihota, and S Fraser;
acquisition and preparation of data: C Lunny; analysis and interpreta-
tion of the data: C Lunny, JA Knopp-Sihota, and S Fraser; risk of bias
assessment: C Lunny and JA Knopp-Sihota; ﬁrst draft of themanuscript:
C Lunny. All authors critically reviewed the manuscript and approved
the ﬁnal version of the manuscript to be published.
Funding
This work was supported by the Academic Research Fund of Atha-
basca University to S Fraser and JA Knopp-Sihota.
Authors' note
We would be grateful if readers would send us reprints of any pub-
lished or unpublished studies on multiple sclerosis and trauma that
have not been included in this paper, as well as any additional data
missed from the included studies.
References
[1] Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environ-
ment. Autoimmun Rev 2010;9(5):A387–94.
[2] Charcot JM. Lectures on thediseasesof thenervous system. London:NewSydenham
Society; 1879 157–222.
[3] Poser CM. Trauma to the central nervous system may result in formation or en-
largement of multiple sclerosis plaques. Arch Neurol 2000;57(7):1074–7 discus-
sion 1078.
[4] Goldacre MJ, Abisgold JD, Yeates DG, Seagroatt V. Risk of multiple sclerosis after
head injury: record linkage study. J Neurol Neurosurg Psychiatry 2006;77(3):
351–3.
[5] Kang JH, Lin HC. Increased risk of multiple sclerosis after traumatic brain injury:
a nationwide population-based study. J Neurotrauma 2012;29(1):90–5.
[6] Siva A, Radhakrishnan K, Kurland LT, O'Brien PC, Swanson JW, Rodriguez M. Trau-
ma and multiple sclerosis: a population-based cohort study from Olmsted County,
Minnesota. Neurology 1993;43(10):1878–82.
[7] Pﬂeger CC, Koch-Henriksen N, Stenager E, Flachs EM, Johansen C. Head injury is not
a risk factor for multiple sclerosis: a prospective cohort study. Mult Scler
2009;15(3):294–8.
[8] Goodin DS, Ebers GC, Johnson KP, Rodriguez M, Sibley WA, Wolinsky JS. The rela-
tionship of MS to physical trauma and psychological stress: report of the Therapeu-
tics and Technology Assessment Subcommittee of the American Academy of
Neurology. Neurology 1999;52(9):1737–45.
[9] Warren SA, Olivo SA, Contreras JF, Turpin KV, Gross DP, Carroll LJ, et al. Traumatic
injury and multiple sclerosis: a systematic review and meta-analysis. Can J Neurol
Sci 2013;40(2):168–76.
[10] The Cochrane Collaboration. In: Higgins J, Green S, editors. Cochrane Handbook for
Systematic Reviews of Interventions Version 5.0.2; 2009 [updated September 2009].[11] Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-
analysis of observational studies in epidemiology: a proposal for reporting.
Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA
2000;283(15):2008–12.
[12] Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple
sclerosis: a meta-analysis. Ann Neurol 2006;59(3):499–503.
[13] Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle–
Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-
analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm; 2009.
[accessed 11 June 2013].
[14] Deeks JJ, Higgins JPT, Altman DG, Higgins J, Green S, editors. Chapter 9: analysing
data and undertaking meta-analysis; Cochrane Handbook for Systematic Reviews
of Interventions Version 5.1.0; 2009 [(updated March 2011). http://handbook.
cochrane.org/chapter_9/9_analysing_data_and_undertaking_meta_analyses.htm
(accessed 11 June 2013)].
[15] Ernst E, Pittler MH. Re-analysis of previous meta-analysis of clinical trials of
homeopathy. J Clin Epidemiol 2000;53(11):1188.
[16] Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of twomethods to
detect publication bias in meta-analysis. JAMA 2006;295(6):676–80.
[17] da Silva KR, Alvarenga RM, Fernandez y Fernandez O, Alvarenga H, Thuler LC. Po-
tential risk factors for multiple sclerosis in Rio de Janeiro: a case–control study.
Arq Neuropsiquiatr 2009;67(2A):229–34.
[18] McAlpine D, Compston N. Some aspects of the natural history of disseminated
sclerosis. QJM 1952;21:135–67.
[19] Cochrane Collaboration. Review Manager (RevMan) [computer program].
Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration;
2011.
[20] Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al.
Chapter 12: interpreting results and drawing conclusions. In: Higgins J, Green S, ed-
itors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0;
2009 [(updated March 2011). http://handbook.cochrane.org/chapter_12/
12_interpreting_results_and_drawing_conclusions.htm (accessed 11 June 2013)].
[21] Beltrán I, Moltó-Jordà JM, Díaz-Marín C, Martín R, Matías-Guiu J. Analytical ep-
idemiological study of multiple sclerosis in Alcoi. Rev Neurol 1998;26(149):
67–9.
[22] Benedikz J,MagnússonH, GuthmundssonG.Multiple sclerosis in Iceland,with obser-
vations on the alleged epidemic in the Faroe Islands. Ann Neurol 1994;36(Suppl. 2):
S175–9.
[23] Boiko A, Deomina T, Favorova O, Gusev E, Sudomoina M, Turetskaya R. Epidemiology
of multiple sclerosis in Russia and other countries of the former Soviet Union: investi-
gations of environmental andgenetic factors. ActaNeurol ScandSuppl 1995;161:71–6.
[24] Di Legge S, Piattella MC, Pozzilli C, Pantano P, Caramia F, Pestalozza IF, et al. Longi-
tudinal evaluation of depression and anxiety in patients with clinically isolated
syndrome at high risk of developing early multiple sclerosis. Mult Scler
2003;9(3):302–6.
[25] Frutos Alegria MT, Beltrán-Blasco I, Quilez-Iborra C, Moltó-Jordá J, Díaz-Marín C,
Matías-Guiu J. The epidemiology of multiples sclerosis in Alcoi. Analytical data.
Rev Neurol 2002;34(9):813–6.
[26] Gusev EI, Boĭko AN, Demina TL, Sudomoina MA, Alekseev AP, Boldyreva MN, et al.
The risk factors for the development of multiple sclerosis in the Moscow popula-
tion. II. The combination of exogenous and hereditary factors. Zh Nevrol
Psikhiatr Im S S Korsakova 1999;99(6):47–52.
[27] Gusev EI, Boĭko AN, Smirnova NF, Demina TL. Risk factors of multiple sclerosis in
Moscow population. I. Exogenous risk factors. Zh Nevrol Psikhiatr Im S S Korsakova
1999;99(5):32–40.
[28] Gusev EI, Zavalishin IA, Boĭko AN, Khoroshilova NL, Iakovlev AP. Epidemiological
characteristics of multiple sclerosis in Russia. Zh Nevrol Psikhiatr Im S S Korsakova
2002(Suppl.: 3–6).
[29] Kahana E, Zilber N, Abramson JH, Biton V, Leibowitz Y, Abramsky O. Multiple scle-
rosis: genetic versus environmental aetiology: epidemiology in Israel updated. J
Neurol 1994;241(5):341–6.
[30] Karnaukh VN. Epidemiology of multiple sclerosis in Amur region. Zh Nevrol
Psikhiatr Im S S Korsakova 2009;109(8):59–62.
[31] Li J, Johansen C, Brønnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J. The
risk of multiple sclerosis in bereaved parents: a nationwide cohort study in
Denmark. Neurology 2004;62(5):726–9.
[32] MeurmanL,Wising P.Multiple sclerosis, tonsillectomy, andherpes zoster varicellosus.
Lakartidningen 1966;63(14):1318–9.
[33] Poser CM. The multiple sclerosis trait and the development of multiple sclerosis:
genetic vulnerability and environmental effect. Clin Neurol Neurosurg 2006;108(3):
227–33.
[34] Souberbielle BE, Martin-Mondiere C, O'Brien ME, Carydakis C, Cesaro P, Degos JD. A
case–control epidemiological study of MS in the Paris area with particular refer-
ence to past disease history and profession. Acta Neurol Scand 1990;82(5):303–10.
[35] Spitzer C, Bouchain M, Winkler LY, Wingenfeld K, Gold SM, Grabe HJ, et al.
Childhood trauma in multiple sclerosis: a case–control study. Psychosom Med
2012;74(3):312–8.
[36] Warren S, Cockerill R, Warren KG. Risk factors by onset age in multiple sclerosis.
Neuroepidemiology 1991;10(1):9–17.
[37] Weilbach FX, Hartung HP. Physical trauma and multiple sclerosis. Nervenarzt
1997;68(12):940–4.
[38] AdamsDK, Sutherland JM, FletcherWB. Early clinicalmanifestations of disseminated
sclerosis. BMJ 1950;2(4676):431–6.
[39] Damadian RV, Chu D. The possible role of cranio-cervical trauma and abnormal CSF
hydrodynamics in the genesis of multiple sclerosis. Physiol Chem Phys Med NMR
2011;41:1–17.
23C.A. Lunny et al. / Journal of the Neurological Sciences 336 (2014) 13–23[40] Elster EL. Eighty-one patients with multiple sclerosis and Parkinson's disease
undergoing upper cervical chiropractic care to correct vertebral subluxation:
a retrospective analysis. J Vertebral Subluxation Res 2004 [Aug: 1–9].
[41] Filippi M, Rocca MA, Martino G, Horsﬁeld MA, Comi G. Magnetization transfer
changes in the normal appearing white matter precede the appearance of enhanc-
ing lesions in patients with multiple sclerosis. Ann Neurol 1998;43(6):809–14.
[42] Hollander E. Trauma, multiple sclerosis, delayed sleep phase disorder, subjective
experiences, and duration of illness in GAD. CNS Spectr 2008;13(5):361–2.
[43] Horton AM, Siegel E. Comparison of multiple sclerosis and head trauma patients:
a neuropsychological pilot study. Int J Neurosci 1990;53(2–4):213–5.
[44] Mutlu N. Multiple sclerosis in Turkey; etiologic and symptomatologic study of four
hundred ten cases. AMA Arch Neurol Psychiatry 1954;71(4):511–6.
[45] Rahman MA, Jayson MI, Black CM. Five patients who developed systemic sclerosis
shortly after episodes of physical trauma. J Rheumatol 1996;23(10):1816–7.
[46] Selcen D, Anlar B, Renda Y. Multiple sclerosis in childhood: report of 16 cases. Eur
Neurol 1996;36(2):79–84.
[47] Stazio A, Paddison RM, Kurland LT.Multiple sclerosis in NewOrleans, Louisiana, and
Winnipeg, Manitoba, Canada: follow-up of a previous survey in New Orleans, and
comparison between the patient populations in the two communities. J Chronic
Dis 1967;20(5):311–32.
[48] Adeleye AO, Olowookere KG, Olayemi OO. Clinicoepidemiological proﬁles and
outcomes during ﬁrst hospital admission of head injury patients in Ikeja, Nigeria.
A prospective cohort study. Neuroepidemiology 2009;32(2):136–41.
[49] Alonso A, Hernan MA, Ascherio A. Allergy, family history of autoimmune diseases,
and the risk of multiple sclerosis. Acta Neurol Scand 2008;117(1):15–20.
[50] Antonovsky A, Leibowitz U, Medalie JM, Smith HA, Halpern L, Alter M. Reappraisal
of possible etiologic factors in multiple sclerosis. Am J Public Health Nations
Health 1968;58(5):836–48.
[51] Banwell B, Bar-Or A, Arnold DL, Sadovnick D, Narayanan S, McGowanM, et al. Clin-
ical, environmental, and genetic determinants of multiple sclerosis in childrenwith
acute demyelination: a prospective national cohort study. Lancet Neurol
2011;10(5):436–45.
[52] Brain R, Wilkinson M. The association of cervical spondylosis and disseminated
sclerosis. Brain 1957;80(4):456–78.
[53] Chaudhuri A, David K, Behari O. 19thWorld Congress ofNeurology, Poster Abstracts.
J Neurol Sci 2009;285(S1):S155–339.
[54] Conradi S, Malzahn U, Schröter F, Paul F, Quill S, Spruth E, et al. Environmental fac-
tors in early childhood are associated with multiple sclerosis: a case–control study.
BMC Neurol 2011;11:123.
[55] Bazarian JJ, Cernak I, Noble-Haeusslein L, Potolicchio S, Temkin N. Long-term neu-
rologic outcomes after traumatic brain injury. J Head Trauma Rehabil 2009;24(6):
439–51.
[56] Jellinek EH. Trauma and multiple sclerosis. Lancet 1994;343(8905):1053–4.
[57] Kranz JM, Kurland LT, Schuman LM, Layton D. Multiple sclerosis in Olmsted and
Mower counties, Minnesota. Neuroepidemiology 1983;2(3–4):106–18.
[58] Lauer K, Firnhaber W. Prognostic criteria in an epidemiological group of patients
with multiple sclerosis: an exploratory study. J Neurol 1992;239(2):93–7.
[59] Mellor A. Case–control study to collect medical and epidemiological data and blood
samples for research into the causes ofmultiple sclerosis and selected demyelinating
diseases. Accelerated Cure Project for MS; 2006 1–18.
[60] Visscher BR, Clark VA, Detels R, Malmgren RM, Valdiviezo NL, Dudley JP. Two pop-
ulations with multiple sclerosis. Clinical and demographic characteristics. J Neurol
1981;225(4):237–49.
[61] Coordinating Center and the Neurological Centers of the Cooperative Group. Coop-
erative Italian study onmultiple sclerosis and risk factors: a case–control study. Ital
J Neurol Sci. The Coordinating Center and the Neurological Centers of the Cooper-
ative Group; 1987 17–20 [Suppl. 6].
[62] Sibley WA, Bamford CR, Clark K, Smith MS, Laguna JF. A prospective study of phys-
ical trauma and multiple sclerosis. J Neurol Neurosurg Psychiatry 1991;54(7):
584–9.
[63] AlterM, Speer J. Clinical evaluation of possible etiologic factors inmultiple sclerosis.
Neurology 1968;18(2):109–16.
[64] Antonovsky A, Leibowitz U, Smith HA, Medalie JM, BaloghM, Kats R, et al. Epidemi-
ologic study of multiple sclerosis in Israel. An overall review of methods and ﬁnd-
ings. Arch Neurol 1965;13:183–93.
[65] Bamford CR, Sibley WA, Thies C, Laguna JF, Smith MS, Clark K. Trauma as an eti-
ologic and aggravating factor in multiple sclerosis. Neurology 1981;31(10):
1229–34.
[66] Berr C, Puel J, Clanet M, Ruidavets JB, Mas JL, Alperovitch A. Risk factors in multiple
sclerosis: a population-based case–control study in Hautes-Pyrenees, France. Acta
Neurol Scand 1989;80(1):46–50.
[67] Bobowick AR, Kurtzke JF, Brody JA, Hrubec Z, Gillespie M. Twin study of multiple
sclerosis: an epidemiologic inquiry. Neurology 1978;28(10):978–87.
[68] Casetta I, Granieri E, Malagù S, Tola MR, Paolino E, Caniatti LM, et al. Environmental
risk factors and multiple sclerosis: a community-based, case–control study in the
province of Ferrara, Italy. Neuroepidemiology 1994;13(3):120–8.
[69] Currier RD, Martin EA, Woosley PC. Prior events in multiple sclerosis. Neurology
1974;24(8):748–54.
[70] De Gennaro RE, Ragazzi E, Caniatti M, Cesnik P, Fazio V, Simioni V, et al. Environ-
mental risk factors in multiple sclerosis. Different exposure in 3 genetically distinctpopulations with analytical approach. XL Congresso Società Italiana di Neurologia,
30. Neurol Sci Suppl; 2009 Nov. p. S110.
[71] Dokuchaeva NN, Boiko AN. Clinical and epidemiological study of multiple sclerosis
in Volgograd city. Zh Nevrol Psikhiatr Im S S Korsakova 2006:4–10 [Spec No 3].
[72] Dolan R. Epidemiological review of the cluster of multiple sclerosis within East
Boston and Winthrop, MA: possible roles of childhood nutrition and xenobiotics
exposure as causative factors for the disease. http://www.areco.org/ms.pdf; 2003.
[accessed 11 June 2013].
[73] FernandezO. Treatmentwith corticoids inmultiple sclerosis. Neurologia 1990;5(7):
233–7.
[74] Ghadirian P, Dadgostar B, Azani R, Maisonneuve P. A case–control study of the as-
sociation between socio-demographic, lifestyle and medical history factors and
multiple sclerosis. Can J Public Health 2001;92(4):281–5.
[75] Goncharova ZA, Baliazin VA. Risk factors of multiple sclerosis development in
the population of the Rostov region. Zh Nevrol Psikhiatr Im S S Korsakova
2009;109(7 Suppl 2):10–5.
[76] Gusev E, Boiko A, Lauer K, Riise T, Deomina T. Environmental risk factors in MS: a
case–control study in Moscow. Acta Neurol Scand 1996;94(6):386–94.
[77] Helmick CG, Wrigley JM, Zack MM, Bigler WJ, Lehman JL, Janssen RS, et al. Multiple
sclerosis in Key West, Florida. Am J Epidemiol 1989;130(5):935–49.
[78] Hopkins RS, Indian RW, Pinnow E, Conomy J. Multiple sclerosis in Galion,
Ohio: prevalence and results of a case–control study. Neuroepidemiology
1991;10(4):192–9.
[79] Koch MJ, Reed D, Stern R, Brody JA. Multiple sclerosis. A cluster in a small North-
western United States community. JAMA 1974;228(12):1555–7.
[80] Koch-Henriksen N. An epidemiological study ofmultiple sclerosis. Familial aggrega-
tion social determinants, and exogenic factors. Acta Neurol Scand Suppl 1989;124:
1–123.
[81] Kurtzke JF, Hyllested K, Arbuckle JD, Brønnum-Hansen H, Wallin MT, Heltberg A.
Multiple sclerosis in the Faroe Islands. Results of a case control questionnaire
with multiple controls. Acta Neurol Scand 1997;96(3):149–57.
[82] Lauer K, Firnhaber W. Descriptive and analytical epidemiological data on multiple
sclerosis from a long-term study in southern Hesse, Germany. In: Firnhaber W,
Lauer C, editors.Multiple sclerosis in Europe: an epidemiological update. Darmstadt:
LTV Press; 1994. p. 147–58.
[83] LeibowitzU, AlterM.Multiple sclerosis. Clues to its cause. Amsterdam:North-Holland
publishing Co; 1973 .
[84] Martinez Sobrepera HJ, Cabrera-Gomez JA, Tuero-Iglesias A. Exogenous factors
in the aetiology of multiple sclerosis in Cuba. A study of cases and controls. Rev
Neurol 2001;33(10):931–7.
[85] Materljan E. Gorski kotar, Croatia, high risk area for multiple sclerosis. PhD Thesis,
University of Rijeka, Croatia; 1994.
[86] Operskalski EA, Visscher BR, Malmgren RM, Detels R. A case–control study of mul-
tiple sclerosis. Neurology 1989;39(6):825–9.
[87] Rudez J, Antonelli L, Materljan E, Sepcić J. Injuries in the etiopathogenesis of multi-
ple sclerosis. Lijec Vjesn 1998;120(1–2):24–7.
[88] Sepcic J, Mesaros E, Materljan E, Sepić-Grahovac D. Nutritional factors andmultiple
sclerosis in Gorski Kotar, Croatia. Neuroepidemiology 1993;12(4):234–40.
[89] von Wilhelm E. Relationship between diseases in childhood and multiple sclerosis.
Schweiz Arch Neurol Neurochir Psychiatr 1970;106(2):311–7.
[90] YoseﬁPour G, Rasekhi A. Multiple sclerosis: a risk factor analysis in Iran. Arch Iran
Med 2002;5(3):191–3.
[91] Zaadstra BM, Chorus AM, van Buuren S, Kalsbeek H, van Noort JM. Selective associ-
ation of multiple sclerosis with infectious mononucleosis. Mult Scler 2008;14(3):
307–13.
[92] Zilber N, Kahana E. Risk factors for multiple sclerosis: a case–control study in Israel.
Acta Neurol Scand 1996;94(6):395–403.
[93] Zorzon M, Zivadinov R, Nasuelli D, Dolﬁni P, Bosco A, Bratina A, et al. Risk factors of
multiple sclerosis: a case–control study. Neurol Sci 2003;24(4):242–7.
[94] Al-Afasy HH, Al-ObaidanMA, Al-Ansari YA, Al-Yatama SA, Al-Rukaibi MS, Makki NI,
et al. Risk factors for multiple sclerosis in Kuwait: a population-based case–control
study. Neuroepidemiology 2013;40(1):30–5.
[95] Westlund KB, Kurland LT. Studies onmultiple sclerosis inWinnipeg, Manitoba, and
New Orleans, Louisiana. II. A controlled investigation of factors in the life history of
the Winnipeg patients. Am J Hyg 1953;57(3):397–407.
[96] Fraser S, Lunny C. Physical trauma risks factors for the development of onset MS:
a US-based prospective case–control study. Unpublished study Athabasca: Atha-
basca University; 2013.
[97] Sterne JAC, Egger M, Moher D. Chapter 10: addressing reporting biases. In: Higgins
J, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions
Version 5.1.0; 2009 [(updated March 2011). http:www.igh.org/Cochrane/tools/
Ch10_Reporting.pdf (accessed 11 June 2013)].
[98] Lew HL, Thomander D, Chew KT, Bleiberg J. Review of sports-related concussion:
potential for application in military settings. J Rehabil Res Dev 2007;44(7):963–74.
[99] Savovic J, Jones H, Altman D, Harris R, Jűni P, Pildal J, et al. Inﬂuence of reported
study design characteristics on intervention effect estimates from randomized,
controlled trials. Ann Intern Med 2012;157(6):429–38.
[100] Compston A.McAlpine's multiple sclerosis. Edinburgh: Churchill Livingstone; 1991.
[101] Kurland LT, Rodriguez M, O'Brien PC, SibleyWA. Physical trauma andmultiple scle-
rosis. Neurology 1994;44(7):1362–4.
